Jay Ramanlal Anand

Statistics

Publications

Citations

217

H-Index

Active since

2012

Affiliations

National Institute of Pharmaceutical Education and Research(Current)

University of North Carolina at Chapel Hill

Universitas Syiah Kuala

University of Illinois Urbana-Champaign

Jay Ramanlal Anand is an author at National Institute of Pharmaceutical Education and Research specializing in oncology, molecular oncology, and life sciences.

ORCID

Publications per year

2012–2024

Publications

Roles of trans-lesion synthesis (TLS) DNA polymerases in tumorigenesis and cancer therapy

Jay Ramanlal Anand, Lilly F. Chiou, Carly A. Sciandra et al. · NAR Cancer · 2023 · 68 citations · Full text

Medicine, Genetics, Oncology +14

Detection of Topoisomerase Covalent Complexes in Eukaryotic Cells

Jay Ramanlal Anand, Yilun Sun, Yang Zhao et al. · Methods in molecular biology · 2017 · 37 citations

Life Sciences, Biochemistry, Molecular Biology +7

Trans-lesion synthesis and mismatch repair pathway crosstalk defines chemoresistance and hypermutation mechanisms in glioblastoma

Xing Cheng, Jing An, Jitong Lou et al. · Nature Communications · 2024 · 30 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Non-HLA gene polymorphisms and their implications on dengue virus infection

Harapan Harapan, Jonny Karunia Fajar, Nur Wahyuniati et al. · Egyptian Journal of Medical Human Genetics · 2012 · 28 citations · Full text

Life Sciences, Genetics, Immunology +17

Etoposide-induced DNA damage is increased in p53 mutants: identification of ATR and other genes that influence effects of p53 mutations on Top2-induced cytotoxicity

Daniel Menéndez, Jay Ramanlal Anand, Carri Murphy et al. · Oncotarget · 2022 · 25 citations · Full text

Medicine, Cancer Biology, Oncology +15

1–5 of 7